Literature DB >> 3308618

[Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].

G Danan1, C Bénichou, B Begaud, M Biour, P Couzigou, J C Evreux, G Lagier, P Berthelot, J P Benhamou.   

Abstract

The use of an official drug adverse reaction assessment procedure became compulsory in France in 1984. The method proposes various qualifications for chronologic and semiologic criteria but does not define them. Consensus meetings have been organized in order to define, in the main pathologic fields, the adverse reactions themselves and the various qualifications of the criteria. This paper reports the results of meetings attended by hepatologists from university hospitals, members of the National Network of pharmacovigilance and representatives of Roussel Uclaf Drug Monitoring Department for drug-induced acute hepatitis. Participants studied (a) the limits of the time interval between the appearance of the adverse reaction and the beginning or the end of the treatment with the suspected drug; (b) the interpretation of the course of disease with or without cessation of treatment; (c) the interpretation of a possible rechallenge; (d) the signs evoking a drug-induced origin and the risk factors, as well as the investigations to be performed in order to eliminate other possible causes.

Entities:  

Mesh:

Year:  1987        PMID: 3308618

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  7 in total

1.  Acute hepatitis due to ketoprofen.

Authors:  J M Nores; S Rambaud; J M Remy
Journal:  Clin Rheumatol       Date:  1991-06       Impact factor: 2.980

2.  Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT).

Authors:  Sinem Ezgi Gulmez; Nicholas Moore; Georges-Philippe Pageaux; Severine Lignot; Yves Horsmans; Bruno Stricker; Jacques Bernuau; Franco Bissoli; Douglas Thorburn; Jean-Louis Montastruc; Sophie Micon; Fatima Hamoud; Régis Lassalle; Jérémy Jové; Patrick Blin; Dominique Larrey
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

3.  Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis.

Authors:  Enzo Ierardi; Nicola Della Valle; Maurizio Cosimo Nacchiero; Vincenzo De Francesco; Giuseppe Stoppino; Carmine Panella
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 4.  Causality assessment in hepatotoxicity by drugs and dietary supplements.

Authors:  Rolf Teschke; Alexander Schwarzenboeck; Karl-Heinz Hennermann
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

Review 5.  Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?

Authors:  Rolf Teschke; Axel Eickhoff; Johannes Schulze
Journal:  J Clin Transl Hepatol       Date:  2013-09-15

Review 6.  RUCAM in Drug and Herb Induced Liver Injury: The Update.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

7.  Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study.

Authors:  Sinem Ezgi Gulmez; Dominique Larrey; Georges-Philippe Pageaux; Severine Lignot; Régis Lassalle; Jérémy Jové; Angelo Gatta; P Aiden McCormick; Harold J Metselaar; Estela Monteiro; Douglas Thorburn; William Bernal; Irene Zouboulis-Vafiadis; Corinne de Vries; Susana Perez-Gutthann; Miriam Sturkenboom; Jacques Bénichou; Jean-Louis Montastruc; Yves Horsmans; Francesco Salvo; Fatima Hamoud; Sophie Micon; Cécile Droz-Perroteau; Patrick Blin; Nicholas Moore
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.